These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 4851412)
1. Distribution of isoniazid inactivators determined in Eskimos and Canadian college students by a urine test. Eidus L; Hodgkin MM; Schaefer O; Jessamine AG Rev Can Biol; 1974 Jun; 33(2):117-23. PubMed ID: 4851412 [No Abstract] [Full Text] [Related]
2. Inactivation of isoniazid by Canadian Eskimos and Indians. Jeanes CW; Schaefer O; Eidus L Can Med Assoc J; 1972 Feb; 106(4):331-5. PubMed ID: 5061127 [TBL] [Abstract][Full Text] [Related]
4. Isoniazid inactivation in Finns and Lapps as demonstrated by various methods. Tittinen H; Mattila MJ; Eriksson AW Am Rev Respir Dis; 1973 Aug; 108(2):375-8. PubMed ID: 4720700 [No Abstract] [Full Text] [Related]
5. Comparison of isoniazid phenotyping of black and white patients with emphasis on South African blacks. Eidus L; Glatthaar E; Hodgkin MM; Nel EE; Kleeberg HH Int J Clin Pharmacol Biopharm; 1979 Jul; 17(7):311-6. PubMed ID: 489198 [TBL] [Abstract][Full Text] [Related]
6. Simplified screening test for phenotyping of isoniazid inactivators. Eidus L; Hodgkin MM Int J Clin Pharmacol; 1973 Feb; 7(1):82-6. PubMed ID: 4699389 [No Abstract] [Full Text] [Related]
7. Determination of the acetylator phenotype using matrix isoniazid. Ellard GA; Gammon PT; Titinen H Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339 [TBL] [Abstract][Full Text] [Related]
8. Isoniazid phenotyping of black as well as white patients. Hodgkin MM; Eidus L; Bailey WC Can J Physiol Pharmacol; 1979 Jul; 57(7):760-3. PubMed ID: 487286 [TBL] [Abstract][Full Text] [Related]
9. [Intermittent drug therapy of tuberculosis: study of the problems involved and summary of the progress made recently in Canada]. Eidus L; Pollak B; Karagoz A; Hodgkin MM Union Med Can; 1974 Jul; 103(7):1271-4. PubMed ID: 4842181 [No Abstract] [Full Text] [Related]
10. Urine test for phenotyping isoniazid inactivators. Eidus L; Harnanansingh AM; Jessamine AG Am Rev Respir Dis; 1971 Oct; 104(4):587-91. PubMed ID: 5094058 [No Abstract] [Full Text] [Related]
11. Effect of prednisolone and rifampin on isoniazid metabolism in slow and rapid inactivators of isoniazid. Sarma GR; Kailasam S; Nair NG; Narayana AS; Tripathy SP Antimicrob Agents Chemother; 1980 Nov; 18(5):661-6. PubMed ID: 7447424 [TBL] [Abstract][Full Text] [Related]
12. Mass phenotyping of isoniazid inactivators by automated determination of acetylisoniazid in urine. Varughese P; Hamilton EJ; Eidus L Clin Chem; 1974 Jun; 20(6):639-41. PubMed ID: 4830165 [No Abstract] [Full Text] [Related]
13. [Determination of isoniazid and acetylisoniazid in the urine for phenotyping isoniazid inactivators]. Yan DX Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1983 Apr; 6(2):71-3. PubMed ID: 6628126 [No Abstract] [Full Text] [Related]
14. Classification of subjects as slow or rapid inactivators of isoniazid based on the ratio of acetylisoniazid to isoniazid in urine determined by a simple colorimetric method. Raghupati Sarma G; Kailasam S; Kannapiran M; Krishnaswami KV; Thomas L; Nair NG; Narayana AS Indian J Med Res; 1976 Oct; 64(10):1456-61. PubMed ID: 1017858 [No Abstract] [Full Text] [Related]
15. Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid. Rao KV; Mitchison DA; Nair NG; Prema K; Tripathy SP Br Med J; 1970 Aug; 3(5721):495-7. PubMed ID: 5454342 [TBL] [Abstract][Full Text] [Related]
16. [Isoniazid acetylation in Gilbert's syndrome]. Pereira-Filho RA; Sevá-Pereira A; de Magalhães AF Arq Gastroenterol; 1985; 22(4):172-5. PubMed ID: 3837656 [TBL] [Abstract][Full Text] [Related]
17. Correlation of sulphadimidine acetylation test in urine and blood for isoniazid phenotyping. Nair CR; Gupta RC; Varshneya AK; Malik SK Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):646-7. PubMed ID: 6526538 [TBL] [Abstract][Full Text] [Related]
18. Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis. Mason E; Russell DW Bull World Health Organ; 1971; 45(5):617-24. PubMed ID: 5316954 [TBL] [Abstract][Full Text] [Related]
19. Phenotyping of South African black tuberculosis patients for inactivation of isoniazid. Eidus L; Glatthaar E; Hodgkin MM; Nel EE; Kleeberg HH Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):243-56. PubMed ID: 461951 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the isoniazid inactivation in Finns and Lapps. Tiitinen H; Mattila MJ; Eriksson AW Ann Med Intern Fenn; 1968; 57(4):161-6. PubMed ID: 5731346 [No Abstract] [Full Text] [Related] [Next] [New Search]